Core Laboratories NV – ‘8-A12B’ on 7/2/98

As of:  Thursday, 7/2/98   ·   Accession #:  950129-98-2886   ·   File #:  1-14273

in

this entire Filing. an “Entity” Search.

Show

Documents searched

and

each “hit”. the 1st “hit”.

↓↑Hints

Registration of a Class of Securities   —   Form 8-A
Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: 8-A12B      Core Laboratories N.V.                                 4     17K 

Document Table of Contents

8-A12B
1st Page of 4
TOC
↑Top
Previous
Next
↓Bottom
Just 1st
 
                                                             Commission File No.

================================================================================

FORM 8-A

SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549

 FOR REGISTRATION OF CERTAIN CLASSES OF SECURITIES
 PURSUANT TO SECTION 12(b) OR (g) OF THE
 SECURITIES EXCHANGE ACT OF 1934

CORE LABORATORIES N.V.
(Exact name of registrant as specified in its charter)

    THE NETHERLANDS                                       NOT APPLICABLE
(State or other jurisdiction of                              (I.R.S. Employer   
incorporation or organization)                             Identification No.)

HERENGRACHT 424                                               
1017 BZ AMSTERDAM                                               
THE NETHERLANDS                                               
     (31-20) 420-3191                                     NOT APPLICABLE
(Address of principal executive offices)                        (Zip Code)      

Securities to be registered pursuant to Section 12(b) of the Act:               

                                             Name of each exchange
 Title of each class to                      on which each class
    be so registered                         is to be registered
     ----------------                         --------------------

        Common Shares,                         New York Stock Exchange
par value NLG 0.03 per share                                        

   If this form relates to the registration of a class of securities
pursuant to Section 12(b) of the Exchange Act and is effective pursuant to      
General Instructions A.(c), check the following box. [X]                        

   If this form relates to the registration of a class of securities
pursuant to Section 12(g) of the Exchange Act and is effective pursuant to      
General Instruction A.(d), check the following box. [ ]                         

Securities to be registered pursuant to Section 12(g) of the Act:               

None

================================================================================

8-A12B
2nd Page of 4
TOC
1st
Previous
Next
↓Bottom
Just 2nd

INFORMATION REQUIRED IN REGISTRATION STATEMENT

ITEM 1.           DESCRIPTION OF REGISTRANT'S SECURITIES TO BE REGISTERED.      

       The class of securities to be registered hereby is the Common Shares,
par value NLG 0.03 per share (the "Common Shares"), of Core Laboratories N.V., a
Netherlands corporation ("Core Laboratories" or the "Company").                 

DESCRIPTION OF SHARE CAPITAL

      Core Laboratories was organized under the laws of The Netherlands by
Deed of Association dated August 4, 1994. Set forth below is a summary of       
certain provisions contained in the Articles of Association and the laws of The 
Netherlands. Such summary does not purport to be complete statements of the     
Articles of Association and the laws of The Netherlands and is qualified in its 
entirety by reference to the Articles of Association and such laws.             

    The authorized share capital of Core Laboratories is NLG 3,090,000
consisting of 100,000,000 Common Shares, each with a par value of NLG 0.03, and 
3,000,000 Preference Shares ("Preference Shares"), each with a par value of NLG 
0.03 (Common Shares and Preference Shares are sometimes collectively referred to
herein as "Shares"). As of June 29, 1998, 24,949,667 Common Shares were         
outstanding. Common Shares and Preference Shares will be issued in registered   
form only. The Transfer Agent and Registrar for the Common Shares is American   
Stock Transfer Company.                                                         

COMMON SHARES                                                                   

    Each shareholder of record is entitled to one vote for each Common
Share held on every matter submitted to a vote of shareholders. In the event of 
the liquidation, dissolution or winding up of the Company, and subject to the   
liquidation preference of holders of Preference Shares, if any, holders of      
Common Shares are entitled to receive, on a pro rata basis, all assets of the   
Company remaining available for distribution to the holders of Common Shares.   
The Articles of Association make no provision for cumulative voting and, as a   
result, the holders of a majority of the Company's voting power will have the   
power to elect all members of the Supervisory Board.                            

PREFERENCE SHARES                                                               

     No Preference Shares are outstanding. The Supervisory Board has the
authority to issue Preference Shares from time to time for a period of five     
years from May 29, 1998, which period may be extended. If such Preference Shares
are issued, holders thereof will be entitled to receive, when, as and if        
declared by the Supervisory Board, dividends at a rate to be determined by the  
Supervisory Board prior to any payment of dividends to the holders of Common    
Shares. In addition, the holders of Preference Shares may be entitled to a      
liquidation preference, payable in the event of any liquidation, dissolution or 
winding up of the Company after satisfaction of any indebtedness but before any 
distribution of assets is made to holders of Common Shares.                     

2 

8-A12B
3rd Page of 4
TOC
1st
Previous
Next
↓Bottom
Just 3rd

     Holders of Preference Shares will have a right to one vote for each
Preference Share held on every matter submitted to a vote of shareholders and   
such holders will vote as a class on matters to be determined by the Supervisory
Board. If issued, the Supervisory Board may designate that the Preference Shares
may be converted into Common Shares under certain specified circumstances. Under
Netherlands law, the Supervisory Board may also authorize the issuance of       
Preference Shares with payment to the Company of up to 75% of the par value of  
such Preference Shares being deferred until such time as it is called by the    
Company. Such issuance of Preference Shares may adversely affect, among other   
things, the voting, dividend and liquidation rights of holders of Common Shares.
The issuance of Preference Shares may have the effect of delaying, deferring or 
preventing a change of control of the Company. The Supervisory Board has no     
present plans to issue any such Preference Shares.                              

SUMMARY OF CERTAIN OTHER MATTERS

PREEMPTIVE RIGHTS                                                               

     The Company's shareholders have authorized the Supervisory Board to
issue such additional authorized but unissued Common Shares as the Supervisory  
Board shall determine. Under the laws of The Netherlands, such authorization can
only be granted for a five-year period and will expire May 28, 2003, subject to 
future extension(s). Subject to the foregoing, under the Articles of            
Association, each holder of Common Shares shall generally have a preemptive     
right to subscribe with regard to any issue of Common Shares pro rata to the    
shareholder's existing holdings of Common Shares, except for certain issuances  
to employees and issuances for noncash consideration.                           

REPURCHASE OF COMMON SHARES                                                     

Subject to certain restrictions contained in the laws of The  
Netherlands and the Articles of Association, the Company currently has the      
authority to acquire its own fully paid shares in an amount not to exceed 10% of
the outstanding shares at any time in open market purchases at any price not to 
exceed $200.00 per share or its equivalent in other currencies. Such            
authorization, which has been granted by the shareholders, may not be granted   
for more than 18 months, is currently valid through November 28, 1999. No such  
authorization will be required if the Company acquires shares in its own capital
for the purpose of transferring the same to employees of the Company or of a    
group company under a scheme applicable to such employees, provided that such   
shares are officially listed on an exchange.                                    

3 

8-A12B
Last Page of 4
TOC
1st
Previous
Next
↓Bottom
Just 4th

 SIGNATURE

  Pursuant to the requirements of Section 12 of the Securities and
Exchange Act of 1934, the registrant has duly caused this registration statement
to be signed on its behalf by the undersigned, thereto duly authorized.         

                              CORE LABORATORIES N.V.

                              BY:  CORE LABORATORIES
                                      INTERNATIONAL B.V.

                                By: /s/ JACOBUS SCHOUTEN
                                               ---------------------------------
                                  Jacobus Schouten
                                   Managing Director

Date:   July 2, 1998                                                            

ITEM 2.            EXHIBITS.                                                    

None required.                                                

4 

Dates Referenced Herein   and   Documents Incorporated by Reference

				Referenced-On Page
This ‘8-A12B’ Filing		Date		First		Last			Other Filings
		5/28/03		3
		11/28/99		3
		7/10/98
Filed on:		7/2/98		4
		6/29/98		2					11-K
		5/29/98		2					DEF 14A,  PRE 14A
		8/4/94		2
									List all Filings

8 Subsequent Filings that Reference this Filing

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

 2/28/23  Core Laboratories Inc./DE         424B3                  1:1.9M                                   Donnelley … Solutions/FA
 2/28/23  Core Laboratories NV              DEFM14A                1:2M                                     Donnelley … Solutions/FA
 2/27/23  Core Laboratories Inc./DE         S-4/A                  1:1.9M                                   Donnelley … Solutions/FA
 2/22/23  Core Laboratories Inc./DE         S-4/A                  7:1.4M                                   Donnelley … Solutions/FA
 1/17/23  Core Laboratories Inc./DE         S-4                    9:1.5M                                   Donnelley … Solutions/FA
 6/09/22  Core Laboratories NV              424B5                  2:440K                                   Donnelley … Solutions/FA
12/17/20  Core Laboratories NV              424B5                  1:330K                                   Donnelley … Solutions/FA
 8/13/20  Core Laboratories NV              S-3ASR      8/13/20    3:320K                                   Donnelley … Solutions/FA